A computational workflow for the design of irreversible inhibitors of protein kinases

被引:0
|
作者
Alberto Del Rio
Miriam Sgobba
Marco Daniele Parenti
Gianluca Degliesposti
Rosetta Forestiero
Claudia Percivalle
Pier Franco Conte
Mauro Freccero
Giulio Rastelli
机构
[1] Università di Modena e Reggio Emilia,Dipartimento di Scienze Farmaceutiche
[2] Università di Pavia,Dipartimento di Chimica Organica
[3] Università di Modena e Reggio Emilia,Dipartimento di Oncologia ed Ematologia
关键词
Protein kinases; ERK2; Irreversible inhibition; Cysteine trap; Michael acceptors; Binding free energy; Molecular dynamics; Generalized amber force field;
D O I
暂无
中图分类号
学科分类号
摘要
Design of irreversible inhibitors is an emerging and relatively less explored strategy for the design of protein kinase inhibitors. In this paper, we present a computational workflow that was specifically conceived to assist such design. The workflow takes the form of a multi-step procedure that includes: the creation of a database of already known reversible inhibitors of protein kinases, the selection of the most promising scaffolds that bind one or more desired kinase templates, the modification of the scaffolds by introduction of chemically reactive groups (suitable cysteine traps) and the final evaluation of the reversible and irreversible protein–ligand complexes with molecular dynamics simulations and binding free energy predictions. Most of these steps were automated. In order to prove that this is viable, the workflow was tested on a database of known inhibitors of ERK2, a protein kinase possessing a cysteine in the ATP site. The modeled ERK2-ligand complexes and the values of the estimated binding free energies of the putative ligands provide useful indicators of their aptitude to bind reversibly and irreversibly to the protein kinase. Moreover, the computational data are used to rank the ligands according to their computed binding free energies and their ability to bind specific protein residues in the reversible and irreversible complexes, thereby providing a useful decision-making tool for each step of the design. In this work we present the overall procedure and the first proof of concept results.
引用
收藏
页码:183 / 194
页数:11
相关论文
共 50 条
  • [21] Dynameomics: design of a computational lab workflow and scientific data repository for protein simulations
    Simms, Andrew M.
    Toofanny, Rudesh D.
    Kehl, Catherine
    Benson, Noah C.
    Daggett, Valerie
    PROTEIN ENGINEERING DESIGN & SELECTION, 2008, 21 (06): : 369 - 377
  • [22] Computational design of orthogonal nucleoside kinases
    Liu, Lingfeng
    Murphy, Paul
    Baker, David
    Lutz, Stefan
    CHEMICAL COMMUNICATIONS, 2010, 46 (46) : 8803 - 8805
  • [23] Design of new irreversible arginase inhibitors
    Guo, Xuefeng
    Seto, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [24] A method for computational combinatorial peptide design of inhibitors of Ras protein
    Zeng, J
    Treutlein, HR
    PROTEIN ENGINEERING, 1999, 12 (06): : 457 - 468
  • [25] Cysteine-targeted Irreversible Inhibitors of Tyrosine Kinases and Key Interactions
    Hu, Chunqi
    Dong, Xiaowu
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (31) : 5811 - 5824
  • [26] The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
    Nitulescu, George Mihai
    Stancov, Gheorghe
    Seremet, Oana Cristina
    Nitulescu, Georgiana
    Mihai, Dragos Paul
    Duta-Bratu, Cosmina Gabriela
    Barbuceanu, Stefania Felicia
    Olaru, Octavian Tudorel
    MOLECULES, 2023, 28 (14):
  • [27] The design of drug candidate molecules as selective inhibitors of therapeutically relevant protein kinases
    Fischer, PM
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (12) : 1563 - 1583
  • [28] Computer-based design of monospecific inhibitors of engineered protein kinases.
    Buzko, OV
    Bishop, AC
    Liu, Y
    Shokat, KM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U599 - U599
  • [29] Design and synthesis of 2(1H)-pyrazinones as inhibitors of protein kinases
    Caldwell, John J.
    Veillard, Nicolas
    Collins, Ian
    TETRAHEDRON, 2012, 68 (47) : 9713 - 9728
  • [30] Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors
    Elagawany, Mohamed
    Ibrahim, Mohamed A.
    Ahmed, Hany Emary Ali
    El-Etrawy, A. Sh
    Ghiaty, Adel
    Abdel-Samii, Zakaria K.
    El-Feky, Said A.
    Bajorath, Juergen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 2007 - 2013